What is the ICD‑10 code for a bone density screening (DXA) for osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Bone Density Screening

For bone density screening (DXA) for osteoporosis, the appropriate ICD-10 code depends on the clinical indication: use Z13.820 for screening for osteoporosis in asymptomatic patients meeting screening criteria, or use specific diagnosis codes (M81.0 for age-related osteoporosis without current pathological fracture, M80.0 with fracture, or M85.8- for osteopenia) when there is already a clinical diagnosis or risk factors present.

Understanding the Coding Context

The choice of ICD-10 code is critical for Medicare and insurance reimbursement, as denial rates for DXA testing vary significantly based on the diagnosis code submitted—ranging from minimal denials to over 40% depending on the code and carrier 1. This makes proper coding essential for ensuring patients receive covered screening.

Primary Screening Codes

For Asymptomatic Screening

  • Z13.820: Encounter for screening for osteoporosis
    • Use this for routine screening in patients who meet age-based criteria (women ≥65 years, men ≥70 years) without current diagnosis 2
    • Also appropriate for younger postmenopausal women with risk factors undergoing initial screening 3

For Established Diagnosis or Clinical Suspicion

  • M81.0: Age-related osteoporosis without current pathological fracture

    • Use when osteoporosis is already diagnosed (T-score ≤ -2.5) 2
  • M85.8-: Other specified disorders of bone density and structure (includes osteopenia)

    • Use when T-score is between -1.0 and -2.5 2
  • M80.0-: Age-related osteoporosis with current pathological fracture

    • Use when patient has sustained a fragility fracture 4

Risk Factor-Based Codes

When screening younger patients with specific risk factors, consider these additional codes:

  • E28.31-: Premature menopause/estrogen deficiency
  • Z87.310: Personal history of osteoporotic fracture
  • Z82.62: Family history of osteoporosis
  • F17.2-: Nicotine dependence (for smokers)
  • Z79.4: Long-term use of insulin (diabetes risk factor)
  • Z79.52: Long-term use of systemic steroids

Clinical Decision Algorithm

Step 1: Determine if patient meets screening criteria 2:

  • Women ≥65 or men ≥70 years → Use Z13.820
  • Younger postmenopausal women/men 50-70 with risk factors → Use Z13.820 plus risk factor codes

Step 2: If prior diagnosis exists:

  • Known osteoporosis → Use M81.0
  • Known osteopenia → Use M85.8-
  • History of fragility fracture → Use M80.0- or Z87.310

Step 3: For monitoring therapy effectiveness:

  • Use the established diagnosis code (M81.0 or M80.0-) rather than screening code 2

Critical Pitfalls to Avoid

Reimbursement timing matters: For repeat DXA scans performed within 23 months, denial rates approach 19% regardless of code, and can reach 43% with certain carriers 1. Medicare typically covers repeat DXA every 23 months unless medically necessary.

Geographic variation: Denial rates vary more than 6-fold between Medicare carriers even with identical codes 1. Verify local carrier requirements before ordering.

Don't use screening codes for established disease: Once osteoporosis is diagnosed, subsequent DXA scans should use the diagnosis code (M81.0), not the screening code (Z13.820), as this is monitoring, not screening 2.

References

Research

Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2008

Guideline

acr appropriateness criteria® osteoporosis and bone mineral density: 2022 update.

Journal of the American College of Radiology, 2022

Research

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014

Related Questions

What are the recommended lifting restrictions for patients with osteoporosis?
In an adult patient who sustained a fracture from a fall from standing height without a DEXA (dual‑energy X‑ray absorptiometry) scan, should osteoporosis be diagnosed?
How should the DEXA scan results (lumbar spine T-score –2.6, left femoral neck T-score –3.2, right femoral neck T-score –2.8, total left –2.8, total right –2.5) and a 5.7% decrease in hip bone density be interpreted in a 71‑year‑old woman?
Is megestrol acetate contraindicated in patients with a history of osteoporosis?
What urine investigations should be performed to evaluate for possible renal causes of osteoporosis?
Can parachute jumping in the Marine Corps cause lumbar strain in a young, healthy adult male Marine?
What withdrawal symptoms can occur when an adult discontinues lisdexamfetamine (Elvanse) 50 mg, and how should the taper be managed?
When should serum luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) be measured in men, and how do the results help differentiate primary versus secondary hypogonadism and guide further evaluation?
What is the recommended trimethoprim‑sulfamethoxazole (Bactrim) dose for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in adults and children, and how should the dose be adjusted for renal impairment or intolerance?
What concentration of Dakin's solution should be used for wound irrigation?
What ICD‑10‑CM code should be used for a colonoscopy performed as a routine screening in an asymptomatic patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.